Skip to product information
1 of 1

INGRAM

Assessing the impact of a safe and equitable biosimilar policy in the United States: hearing before the Subcommittee on Health of the Committee on Ene

Regular price $13.99 USD
Regular price Sale price $13.99 USD
Sale Sold out
Title
Assessing the impact of a safe and equitable biosimilar policy in the United States: hearing before the Subcommittee on Health of the Committee on Ene - United States House of Representatives